SCHEMBL4657946

SCHEMBL4657946

Cc1ccc(N)c2c(C)ccc(N)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.46
TDP1 Q9NUW8 6/20 0.46
TSHR P16473 5/20 0.46
ALDH1A1 P00352 4/20 0.46
CASP1 P29466 2/20 0.46
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.39
CD44 P16070 1/20 0.39
MAPK1 P28482 1/20 0.38
PIK3CA P42336 1/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
MAPT P10636 2/20 0.37
S100B P04271 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20380560 0.97 CYP3A4 (0.43) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL25144754 0.97 CYP3A4 (0.43) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL11815258 0.90 CYP3A4 (0.43) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL17979665 0.77 CYP1A2 (0.46) CYP3A4TDP1TSHRALDH1A1THRB
SCHEMBL17402717 0.77 CYP1A2 (0.52) CYP3A4TDP1TSHRALDH1A1SMN1; SMN2
SCHEMBL4658237 0.77 ALDH1A1 (0.52) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL28490 0.77 POLB (0.39) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL31001032 0.73 CYP1A2 (0.44) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL597313 0.73 CYP1A2 (0.44) CYP3A4TDP1TSHRALDH1A1CASP1
SCHEMBL806350 0.73 CYP3A4 (0.43) CYP3A4TDP1TSHRALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD CYP3A4 154/4885TDP1 234/4885TSHR 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.